Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool
暂无分享,去创建一个
[1] S. Holmberg,et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. , 1992, The New England journal of medicine.
[2] R. Perdigoto,et al. Liver transplantation for familial amyloid polyneuropathy. , 1998, Hepato-gastroenterology.
[3] M. Eisner,et al. Aggressive management of lung donors classified as unacceptable: excellent recipient survival one year after transplantation. , 2002, The Journal of thoracic and cardiovascular surgery.
[4] H. Laks,et al. Hepatitis C‐positive Donors in Heart Transplantation , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] J. Córdoba,et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti‐HBc positivity in the donor population , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[6] D. Samuel,et al. Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy , 1999 .
[7] S. Knechtle,et al. Successful extrarenal transplantation from non-heart-beating donors. , 1995, Transplantation.
[8] E. Capouya,et al. Orthotopic heart transplantation and concurrent coronary bypass. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] A. López-Navidad,et al. The medical-nursing team specialized in the maintenance of the brain-dead heart-beating organ donor exclusively dedicated to caring for the donor reduces donor loss from asystolia to zero. , 2002, Transplantation proceedings.
[10] M. Castagneto,et al. Successful transplantation of an injured liver. , 2000, Transplantation proceedings.
[11] S. Gore,et al. Organs for transplantation. , 1990, BMJ.
[12] P. Kuo,et al. Use of renal allografts from donors positive for hepatitis B core antibody confers minimal risk for subsequent development of clinical hepatitis B virus disease. , 1997, Transplantation.
[13] D. Paredes,et al. Renal transplantation with limit donors: to what should the good results obtained be attributed? , 1998, Transplantation.
[14] D. Hickey,et al. Successful transplantation of kidneys from a donor with HELLP syndrome-related death , 2001, Transplant international : official journal of the European Society for Organ Transplantation.
[15] B. Pereira,et al. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus) , 2002, Transplant infectious disease : an official journal of the Transplantation Society.
[16] S. Goodnight,et al. Disseminated intravascular coagulation in cadaveric organ donors. Incidence and effect on renal transplantation. , 1993, Transplantation.
[17] G. Remuzzi,et al. Strategies for making more organs available for transplantation. , 2000, The New England journal of medicine.
[18] Michael C. Richardson,et al. A survey of liver transplantation from living adult donors in the United States. , 2003, The New England journal of medicine.
[19] J. Emond,et al. Optimizing the use of donated cadaver livers: Analysis and policy development to increase the application of split‐liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[20] Y. Becker,et al. Liver transplantation from controlled non-heart-beating donors. , 2000, Surgery.
[21] D. Freimark,et al. Donors with a history of cocaine use: effect on survival and rejection frequency after heart transplantation. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[22] W. S. Ring,et al. Consensus Conference Report , 2002 .
[23] B. Gridelli,et al. Extensive use of split liver for pediatric liver transplantation: A single‐center experience , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[24] H. Laks,et al. The alternate recipient list for heart transplantation: a model for expansion of the donor pool. , 1999, Advances in cardiac surgery.
[25] U. Kunzendorf,et al. Duration of Donor Brain Death and its Influence on Kidney Graft Function , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[26] S. Chamaret,et al. FATAL ACUTE HIV INFECTION WITH APLASTIC ANAEMIA, TRANSMITTED BY LIVER GRAFT , 1988, The Lancet.
[27] G. Kootstra,et al. Horseshoe kidney transplantation: an overview , 2000, Clinical transplantation.
[28] F. Delmonico. Cadaver donor screening for infectious agents in solid organ transplantation. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] V. Jeevanandam,et al. Standard criteria for an acceptable donor heart are restricting heart transplantation. , 1996, The Annals of thoracic surgery.
[30] R. Chari,et al. Domino liver transplantation for familial amyloid polyneuropathy. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[31] D. Snydman,et al. Outcome of transplantation of organs procured from bacteremic donors. , 1999, Transplantation.
[32] S. Muñoz,et al. Use of hepatitis B core antibody–positive donors for liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[33] S. Natov,et al. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus) , 2002, Transplant infectious disease : an official journal of the Transplantation Society.
[34] Successful use of kidneys from diabetic cadaver kidney donors: 67- and 44-month graft survival. , 1994, Transplantation.
[35] J. Fung,et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. , 1997, Transplantation.
[36] H. Rilo,et al. Transmission of donor cancer into cardiothoracic transplant recipients. , 2001, Surgery.
[37] S. Kapur,et al. Strategies to expand the donor pool for pancreas transplantation. , 1998, Transplantation.
[38] O. Jonasson,et al. Reye syndrome cadaveric kidneys: their use in human transplantation. , 1974, Archives of surgery.
[39] J. Morales,et al. Reuse of a transplanted kidney. , 1993, The New England journal of medicine.
[40] J. Coburn,et al. Transplantation of Cadaveric Kidneys from Patients with Hepatorenal Syndrome , 1969 .
[41] J. Rosenthal,et al. Transplantation of cadaver kidneys from a donor with crossed nonfused renal ectopia. , 1989, The Journal of urology.
[42] G. Klintmalm,et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. , 1998, Transplantation.
[43] 藤田 みさお. 「肝右葉切除術による成人間生体肝移植」, Trotter JF, Wachs M, Everson GT, et al, Adult-to-adult transolantation of the right hepatic lobe from a living donor, N Engl J Med 346, 1074-1082, 2002 , 2003 .
[44] M. Goormastic,et al. Outcome ofDe Novohepatitis C virus infection in heart transplant recipients , 1999, Hepatology.
[45] S. Caldwell. Hard times and imperfect organs. , 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[46] D. Gjertson,et al. Transplantation of kidneys from donors whose hearts have stopped beating. , 1998 .
[47] W. Maley,et al. Shorter waiting times for hepatitis C virus seropositive recipients of cadaveric renal allografts from hepatitis C virus seropositive donors , 2000, Clinical transplantation.
[48] T. Theruvath,et al. Strategies to improve long-term outcomes after renal transplantation. , 2002, The New England journal of medicine.
[49] J. Turcotte,et al. TRANSPLANTATION OF INFECTED KIDNEYS CLINICAL AND EXPERIMENTAL RESULTS , 1979, Transplantation.
[50] G. Tenderich,et al. Hemodynamic follow-up of cardiac allografts from poisoned donors. , 1998, Transplantation.
[51] F. Mosca,et al. Changing typology of brain death liver donors: characteristics and impact of risk factors on short-term outcome. , 2002, Hepato-gastroenterology.
[52] A. Rosenklint,et al. BRAIN DEATH PATHOGENESIS AND DIAGNOSIS , 1973, Acta neurologica Scandinavica.
[53] T. Fishbein,et al. Use of livers with microvesicular fat safely expands the donor pool. , 1997, Transplantation.
[54] A. López-Navidad,et al. Donor age and cause of brain death influence the number of organs retrieved and grafted. , 1999, Transplantation proceedings.
[55] T. Yoshioka,et al. Long-term renal preservation after brain death maintained with vasopressin and epinephrine , 1990, Transplant international : official journal of the European Society for Organ Transplantation.
[56] F. Delmonico,et al. Transplant tumor registry: donors with central nervous system tumors1. , 2002, Transplantation.
[57] J. Morales,et al. Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. , 1995, Kidney international.
[58] E. Moreno gonzález,et al. An approach to the rational use of steatotic donor livers in liver transplantation. , 1999, Hepato-gastroenterology.
[59] W. Saxinger,et al. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. , 1987, Annals of internal medicine.
[60] P. Seu,et al. In situ splitting of the cadaveric liver for two adult recipients. , 2001, Transplantation.
[61] I. Gonzalez-Pinto,et al. Successful reuse of a liver graft , 1991, The British journal of surgery.
[62] J. Aguado,et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] S. Wigmore,et al. Kidney damage during organ retrieval: data from UK National Transplant Database , 1999, The Lancet.
[64] D. Samuel,et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors , 2002, Gut.
[65] F. Richard,et al. Successful kidney transplantation using organs from a donor with disseminated intravascular coagulation and impaired renal function: case report and review of the literature. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[66] A. Więcek,et al. [Is it possible to transplant kidneys from donors whose death was caused by ethylene glycol intoxication?]. , 1993, Polskie Archiwum Medycyny Wewnetrznej.
[67] B. Radovancević,et al. Use of potentially infected donor hearts for cardiac transplantation. , 1990, The Annals of thoracic surgery.
[68] H. Ekberg,et al. Estimated and Measured Donor Creatinine Clearance are Poor Predictors of Long‐Term Renal Graft Function and Survival , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[69] A. Tzakis,et al. The presence of hepatitis B core antibody does not preclude kidney donation: lack of viral DNA in the serum and biopsies of core antibody-positive donors and clinical follow-up. , 1997, Transplantation.
[70] G. Persijn,et al. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation1 , 2001, Transplantation.
[71] H. Morita,et al. Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction. , 1999, The American journal of cardiology.
[72] Transplantation and 2-year follow-up of kidneys procured from a cadaver donor with a history of lupus nephritis. , 2000, Transplantation.
[73] J. Wallwork,et al. Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[74] R. Wolfe,et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. , 2001, Journal of the American Society of Nephrology : JASN.
[75] C. Tribble,et al. Successful Transplantation of Marginally Acceptable Thoracic Organs , 1993, Annals of surgery.
[76] S. A. Kumar,et al. REVERSAL OF DIABETIC NEPHROPATHY IN HUMAN CADAVERIC KIDNEYS AFTER TRANSPLANTATION INTO NON-DIABETIC RECIPIENTS , 1983, The Lancet.
[77] L. Macé,et al. Adult heart transplantation: adverse role of chronic alcoholism in donors on early graft function. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[78] M. Rela,et al. Results of Split Liver Transplantation in Children , 2002, Annals of surgery.
[79] A. Levey,et al. Hepatitis C virus infection in dialysis and renal transplantation. , 1997, Kidney international.
[80] W. Vigneswaran,et al. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[81] P. Coriat,et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients , 1998, The Lancet.
[82] F. Delmonico,et al. Aggressive pharmacologic donor management results in more transplanted organs1 , 2003, Transplantation.
[83] C. Seiler,et al. Echocardiographic evaluation of left ventricular wall motion before and after heart transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[84] M. Mihatsch,et al. Morphologic findings in "zero-hour" biopsies of renal transplants. , 1991, Clinical nephrology.
[85] D. Goldfarb,et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. , 2003, The Journal of urology.
[86] F. Delmonico,et al. FIRST REPORT OF THE UNITED NETWORK FOR ORGAN SHARING TRANSPLANT TUMOR REGISTRY: DONORS WITH A HISTORY OF CANCER1 , 2000, Transplantation.
[87] E. Collisson,et al. A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 Patients , 2001, Annals of surgery.
[88] H. Isoniemi,et al. Fulminant hepatic failure: Outcome after listing for highly urgent liver transplantation—12 years experience in the nordic countries , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[89] P. Andrews. Renal transplantation , 2002, BMJ : British Medical Journal.
[90] J. Kobashigawa,et al. The use of donor hearts with left ventricular hypertrophy. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[91] D. Hricik,et al. Renal transplantation using a kidney with a large benign cyst. , 1997, Transplantation.
[92] T. Lifshitz,et al. [The toxic patient as a potential organ donor]. , 2000, Harefuah.
[93] J. Fung,et al. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. , 1999, Transplantation.
[94] H. Lloyd-Jones,et al. An approach to the retrieval of thoracic organs for transplantation. , 1996, AORN journal.
[95] A. Demetris,et al. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis1 , 2002, Transplantation.
[96] E. González,et al. Riesgo de transmisión del virus de la hepatitis B de donantes de hígado anti-HBc positivos , 2001 .
[97] W. S. Ring,et al. Maximizing use of organs recovered from the cadaver donor: Cardiac recommendations , 2002 .
[98] M. Frutos,et al. Successful transplant of a liver from a kidney transplant recipient 11 years after transplantation. , 2000, Transplantation.
[99] F. Delmonico,et al. Report of the Crystal City Meeting to Maximize the Use of Organs Recovered from the Cadaver Donor , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[100] G. Alexander,et al. Risk of inappropriate exclusion of organ donors by introduction of hepatitis B core antibody testing. , 1997, Transplantation.
[101] S Takemoto,et al. High survival rates of kidney transplants from spousal and living unrelated donors. , 1995, The New England journal of medicine.
[102] R. Chung,et al. Approach to the Management of Allograft Recipients Following the Detection of Hepatitis B Virus in the Prospective Organ Donor , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[103] S. Krähenbühl,et al. Safety of liver donation after fatal intoxication with the tricyclic antidepressant trimipramine. , 1996, Transplantation.
[104] A. López-Navidad,et al. Successful transplantation of organs from a donor who died from acute cocaine intoxication , 2003, Clinical transplantation.
[105] J. Emond,et al. The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ Donors , 1995, Transplantation.
[106] C. Santiago,et al. Successful transplantation of organs retrieved from donors with bacterial meningitis. , 1997, Transplantation.
[107] L. Grande,et al. Liver transplant with organs from elderly donors: Spanish experience with more than 300 liver donors over 70 years of age. , 2002, Transplantation.
[108] F. Merkel. Transplantation of small en bloc kidneys including a horseshoe kidney from donors aged 2 to 60 months to adult recipients: a 13-year experience. , 2001, Transplantation proceedings.
[109] I. García,et al. Use of octogenarian livers safely expands the donor pool. , 1999 .
[110] H. Meier‐Kriesche,et al. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A Paired Donor Kidney Analysis1 , 2002, Transplantation.
[111] G. Everson,et al. Adult-to-adult transplantation of the right hepatic lobe from a living donor. , 2002, The New England journal of medicine.
[112] K. Woodside,et al. Progression of hepatic damage during cold storage after procurement in a liver and kidney donor with HELLP syndrome. , 2001, Transplantation.
[113] M. Durão,et al. Kidney transplantation from donors without a heartbeat. , 2002, The New England journal of medicine.
[114] M. Stoller,et al. Donor-gifted allograft urolithiasis: early percutaneous management. , 2002, Urology.
[115] T. Starzl,et al. Experience with liver and kidney allografts from non-heart-beating donors. , 1995, Transplantation.
[116] T. Howard,et al. Transplant recipients as organ donors: the domino transplant. , 1997, Transplantation proceedings.
[117] V. Maffettone,et al. Reuse of Liver Grafts after Early Death of the First Recipient , 1996, World Journal of Surgery.
[118] C. Schmid,et al. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement. , 1997, Transplantation.
[119] S. Flier,et al. Luxury primary care. , 2002, The New England journal of medicine.
[120] U. Settmacher,et al. Polycystic liver grafts for orthotopic liver transplantation. , 2000, Transplantation proceedings.
[121] M. Schwartz,et al. Safe use of hepatic allografts from donors older than 70 years. , 1996, Transplantation.
[122] P. Hantson,et al. Organ procurement after evidence of brain death in victims of acute poisoning. , 1997, Transplantation proceedings.
[123] E. Schiff,et al. Are liver grafts from hepatitis B surface antigen negative/anti-hepatitis B core antibody positive donors suitable for transplantation? , 2001, Transplantation proceedings.
[124] K. Olthoff,et al. The outcome of liver grafts procured from hepatitis C-positive donors. , 2002, Transplantation.
[125] M. Moal,et al. Kidney transplantations with HBsAg+ donors. , 1993, Transplantation proceedings.
[126] J B Seward,et al. Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[127] R. Bolman,et al. Liberalization of donor criteria in lung and heart-lung transplantation. , 1994, The Annals of thoracic surgery.
[128] M. Polley. Renal transplantation. , 1967, Nursing times.
[129] L. Bennett,et al. The expanded donor , 1997 .
[130] R. Hetzer,et al. Medium-term results of heart transplantation using donors over 63 years of age. , 1999, Transplantation.
[131] S. Geller,et al. Transmission of hepatitis B infection from hepatitis B core antibody–positive liver allografts is prevented by lamivudine therapy , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[132] S. Hariharan,et al. Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data. , 2001, Transplantation.
[133] H. Ott,et al. Successful transfer of a cardiac allograft from a heterotopic to an orthotopic position 16 years after transplantation. , 2002, Transplantation.
[134] R. Freeman,et al. Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policy , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[135] K. Gottesdiener. Transplanted infections: donor-to-host transmission with the allograft. , 1989, Annals of internal medicine.
[136] W. Marks,et al. Transplant tumor registry: donor related malignancies , 2002, Transplantation.
[137] M. Fisman. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. , 1986, The New England journal of medicine.
[138] H. Ekberg,et al. Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot alone discriminate for acceptance of marginal donors. , 2000, Transplantation.
[139] A. Sánchez-Fructuoso,et al. Non-heart beating donors. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[140] Gina Pugliese,et al. Creutzfeldt-Jakob Disease Recommendations for Disinfection and Sterilization , 2001, Infection Control & Hospital Epidemiology.
[141] F. Ruíz,et al. Non-heart-beating donors from the streets: an increasing donor pool source. , 1999, Transplantation.
[142] Randall G. Lee,et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. , 1999, Gastroenterology.
[143] C. Rogers,et al. Variations in cardiac transplantation: comparisons between the United Kingdom and the United States. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[144] R. Wiesner,et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. , 1997, Gastroenterology.
[145] J. Cotorruelo,et al. Ecstasy-induced brain death and acute hepatocellular failure: multiorgan donor and liver transplantation , 2002, Transplantation.
[146] Chao-Long Chen,et al. Hepatitis B core antibody-positive grafts: recipient’s risk , 2003, Transplantation.
[147] C. C. Richardson,et al. Renal transplantation in Reye's syndrome: fate of the recipient--a case report. , 1979, The Journal of urology.
[148] R. Novick,et al. Effect of donor age and ischemic time on intermediate survival and morbidity after lung transplantation. , 2000, Chest.
[149] M. Meurisse,et al. Organ donors with primary central nervous system tumor. , 2000, Transplantation.
[150] Bm Bm. Características de los donantes renales en España: Factores de riesgo y órganos desechados para trasplante , 2001 .
[151] S. Fan,et al. Transplantation of the right hepatic lobe. , 2002, The New England journal of medicine.
[152] M. Pasic,et al. Reuse of a Transplanted Heart , 1993 .
[153] R. Wolfe,et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[154] S. Jordan,et al. IMPACT OF HEPATITIS B CORE ANTIBODY STATUS ON OUTCOMES OF CADAVERIC RENAL TRANSPLANTATION: ANALYSIS OF UNITED NETWORK OF ORGAN SHARING DATABASE BETWEEN 1994 AND 1999 , 2002, Transplantation.
[155] I. Gich,et al. Elderly donor kidney grafts into young recipients: results at 5 years , 2002, Transplantation.
[156] N. Terrault,et al. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation , 2002, Transplantation.
[157] Y. Becker,et al. Diabetic kidneys can safely expand the donor pool , 2002, Transplantation.
[158] D. V. van Thiel,et al. Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation. , 2002, Archives of surgery.
[159] S. Chu,et al. Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[160] D. Snydman,et al. Organ donor screening for infectious diseases: review of practice and implications for transplantation. , 1998, Transplantation.
[161] F. March,et al. Epidemiologic evidence of transmission of donor-related bacterial infection through a transplanted heart. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[162] R. Stratta,et al. FROZEN SECTION EVALUATION OF DONOR LIVERS BEFORE TRANSPLANTATION , 1993, Transplantation.
[163] H. Shidban,et al. Risks of transplanting kidneys from hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors. , 1997, Transplantation.
[164] B. Kasiske,et al. EVALUATION OF LIVING RENAL DONORS THE CURRENT PRACTICE OF US TRANSPLANT CENTERS , 1995, Transplantation.
[165] Jorge Ortiz,et al. Safe use of livers from donors with positive hepatitis B core antibody , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[166] A. Lu,et al. Severe glomerular sclerosis is not associated with poor outcome after kidney transplantation. , 2000, American journal of surgery.
[167] B. Meiser,et al. One heart transplanted successfully twice. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[168] M. Potts. Transplantation of the right hepatic lobe. , 2002, The New England journal of medicine.
[169] H. Joller-jemelka,et al. Hepatitis C RNA prevalence in a Western European organ donor pool and virus transmission by organ transplantation. , 1994, Journal of medical microbiology.
[170] J. Córdoba,et al. Is there any risk of transmission of hepatitis B from heart donors hepatitis B core antibody positive? , 2002, Transplantation proceedings.
[171] T. P. Suñé,et al. Criterios de selección del donante de órganos respecto a la transmisión de infecciones , 1999 .
[172] J. D. De Goyet,et al. The use of liver grafts from donors with bacterial meningitis. , 2001, Transplantation.
[173] C. Tomson,et al. Successful transplant of a kidney with focal segmental glomerulosclerosis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[174] J. Figueras,et al. Recipients and donors: a life-paradox. , 1999, Transplantation proceedings.
[175] Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody--North Carolina. , 1987, MMWR. Morbidity and mortality weekly report.
[176] J. Torras,et al. A good alternative to reduce the kidney shortage: kidneys from nonheartbeating donors. , 1998, Transplantation.
[177] B. Croker,et al. FATE OF FOUR CADAVERIC DONOR RENAL ALLOGRAFTS WITH MESANGIAL IgA DEPOSITS , 1982, Transplantation.
[178] G. Loss,et al. Transplantation of livers from HBc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results , 2001, Clinical transplantation.
[179] A. Vizjak,et al. IgA nephropathy as a donor-transmitted disease in renal transplant recipients. , 1991, Transplantation proceedings.
[180] G. Tenderich,et al. Extended donor criteria: hemodynamic follow-up of heart transplant recipients receiving a cardiac allograft from donors > or = 60 years of age. , 1998, Transplantation.
[181] I. Penn. The problem of cancer in organ transplant recipients: an overview. , 1994, Transplantation science.
[182] G Usera,et al. Double versus single renal allografts from aged donors. , 1999, Transplantation.
[183] A. Lok,et al. THE IMPACT OF DONOR AND RECIPIENT HEPATITIS B SURFACE ANTIGEN STATUS ON LIVER DISEASE AND SURVIVAL IN RENAL TRANSPLANT RECIPIENTS , 1992, Transplantation.
[184] S. Gundry,et al. Donor shortage: use of the dysfunctional donor heart. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[185] A. López-Navidad,et al. For a rational approach to the critical points of the cadaveric donation process. , 2001, Transplantation proceedings.
[186] D. Nghiem. Procurement of transplantable organs from brain dead transplant recipients. , 1997, Transplantation proceedings.
[187] M. Kirk,et al. Organ Procurement and Successful Transplantation After Malathion Poisoning , 2001, Journal of toxicology. Clinical toxicology.
[188] G. Ercolani,et al. A Revised Consideration on the Use of Very Aged Donors for Liver Transplantation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[189] J. Wallwork,et al. Excellent outcome of cardiac transplantation using domino donor hearts. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[190] D. DeMeo,et al. Clinical status of lung transplantation. , 2001, Transplantation.
[191] D. Kaminski,et al. Orthotopic liver transplantation resulting in amitriptyline toxicity in the recipient. , 1989, Transplantation.
[192] A. Collins,et al. Does cadaveric donor renal transplantation ever provide better outcomes than live-donor renal transplantation?1,2 , 2003, Transplantation.
[193] O. Grandas,et al. Donor hepatitis C virus status does not adversely affect short-term outcomes in HCV+ recipients in renal transplantation. , 1998, Transplantation.
[194] D. Hernández-Gallardo,et al. Successful transplantation of a liver graft with a calcified hydatid cyst after back-table resection. , 1995, Transplantation.
[195] Chao-Long Chen,et al. Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors , 2002, Clinical transplantation.
[196] L. Gesualdo,et al. Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions , 2002, Transplantation.
[197] L. Ratner,et al. Expanded criteria donors: attempts to increase the renal transplant donor pool. , 2000, Advances in renal replacement therapy.
[198] S. Steen,et al. Transplantation of lungs from a non-heart-beating donor , 2001, The Lancet.
[199] G. Davis,et al. Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient. , 1994, Transplantation.
[200] J. Miller,et al. Unilateral donor lung dysfunction does not preclude successful contralateral single lung transplantation. , 1992, The Journal of thoracic and cardiovascular surgery.
[201] F. Ginevri,et al. A liver transplant candidate (fulminant hepatic failure from amanita phalloides poisoning) as a multiorgan donor. , 1997, Transplantation proceedings.
[202] C. Létoublon,et al. Use of grafts procured from organ transplant recipients. , 1999, Transplantation.
[203] J. Figueras,et al. Successful transplantation of organs retrieved from a donor with enterococcal endocarditis , 1998, Transplant international : official journal of the European Society for Organ Transplantation.
[204] F. Delmonico,et al. Living kidney donors in need of kidney transplants: a report from the organ procurement and transplantation network. , 2002, Transplantation.
[205] V. Calvo,et al. Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group. , 1999, Chest.
[206] D. Little,et al. Donor sepsis is not a contraindication to cadaveric organ donation. , 1997, QJM : monthly journal of the Association of Physicians.
[207] A. López-Navidad,et al. Short‐ and long‐term success of organs transplanted from acute methanol poisoned donors , 2002, Clinical transplantation.